Valent and other authors described that CD34+/CD38−/Lin− CML LSCs specifically co-express CD26 and that its expression appears to discriminate CML LSCs from normal HSCs [6,48]. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.